All USA & Canada articles – Page 58
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsImmune cells prevent lung healing after viral infection
Investigators have discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
-
NewsObesity may increase susceptibility to contracting COVID-19
Electronic health record data revealed that individuals with obesity were 34% more likely to become COVID positive after reported exposure than individuals without obesity.
-
NewsInvestigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
A new mpox vaccine candidate more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine.
-
NewsH5 influenza vaccines: what needs to be done to reduce the risk of a pandemic
As the global threat of H5N1 influenza looms, three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats.
-
NewsNewly discovered viruses in parasitic nematodes could change our understanding of how they cause disease
New research shows that parasitic nematodes, responsible for infecting more than a billion people globally, carry viruses that may solve the puzzle of why some cause serious diseases.
-
NewsResearchers develop tool that measures health of a person’s gut microbiome
A team of researchers has developed an innovative computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses and other microorganisms within the digestive system, to provide insights into overall well-being.
-
NewsDangerous airborne fungus boosted by California droughts
By analyzing data on reported cases of Valley fever in California, which have increased dramatically over the last two decades, researchers have identified seasonal patterns that could help TO prepare for future surges in Valley fever cases.
-
NewsNewly discovered antibody protects against all COVID-19 variants
Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.
-
NewsScientists unlock the secret behind a decades-old dengue mystery
A study has pinpointed a mutation in the dengue virus’ genome as the root cause of a 1970s outbreak of dengue in the South Pacific, which impaired the virus’ ability to replicate in human cells, resulting in a low virus load and asymptomatic infections in patients.
-
NewsNIH awards will support innovation in syphilis diagnostics
NIAID has awarded grants for 10 projects to improve diagnostic tools for congenital and adult syphilis—conditions currently diagnosed with a sequence of tests, each with limited precision.
-
NewsResearcher explores wastewater’s role in antimicrobial resistance
An Oregon State University researcher will receive $2.35 million from the Environmental Protection Agency to explore what happens to antibiotics, antibiotic-resistant bacteria and their genes after they reach wastewater systems throughout the United States.
-
NewsThe apple’s battle plan: Unraveling the molecular response to fungal infections
A new study reveals critical insights into how apple trees respond to Glomerella leaf spot (GLS), a severe fungal disease impacting apple yields, and offers promising pathways for breeding disease-resistant apple varieties.
-
NewsScientists seek more effective treatment for under-the-radar STI
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
-
NewsResearchers find that aoudad and bighorn sheep share respiratory pathogens
Both species may contribute to disease recirculation among each other’s populations, and diseases that have already devastated bighorns could be present in aoudad with unknown effects.
-
NewsSmart mask monitors breath for signs of disease and infection
Researchers have developed a prototype for a smart mask that can be used to monitor a range of medical conditions, including respiratory ailments, such as asthma, COPD (chronic obstructive pulmonary disease), and post-COVID-19 infections.
-
NewsDormancy defence systems show us why phages may not be the answer to everything
Toxin/antitoxin defence systems in bacteria need to be better understood if the potential of phage therapy is to be realised, a new review in Sustainable Microbiology suggests.